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Background: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) requires consideration of a patient’s resources to take 
prolonged dual antiplatelet therapy (DAPT). We aimed to evaluate whether insurance type influences the likelihood of receiving DES.
Methods: During the DES era (April 2003 forward) we compared 9389 patients undergoing PCI with at least 1 DES to 3195 patients undergoing 
PCI without DES. We defined primary insurance at discharge as private, Medicare, Medicaid, or uninsured. We performed multivariable logistic 
regression, with receipt of DES as the outcome, to adjust for confounders.
Results: Overall, 49.0% of patients had private insurance, 45.3% had Medicare, 3.6% had Medicaid, and 2.1% no insurance. Patients receiving 
DES were less likely to be African American (24.3 vs. 31.0%, p <0.001) or to present acutely (13.6% vs. 31.8%, p <0.001). Patients receiving 
DES also had less comorbidities like congestive heart failure. Unadjusted death rates at 1 year were lower with DES (6.5% vs. 24.1%, p <0.001). 
Multivariable logistic regression showed that receipt of DES was less likely for patients with Medicare (OR 0.83, 95% CI 0.74-0.94), Medicaid (OR 
0.58, 95% CI 0.47-0.73), or no insurance (OR 0.58, 95% CI 0.44-0.77), compared to private insurance. (Figure)
Conclusion: Patients with government-sponsored insurance or no insurance are less likely to receive DES. 
The root of this disparity is unclear, but may be due to physician-perceived practicality of prolonged DAPT.
